Sustained Drug Delivery Systems for Treatment of Age Related Macular Degeneration: A Review

نویسندگان
doi
چکیده

The number of people with age-related visual problems, such as macular degeneration, has increased in recent decades due to population aging. Currently, many pharmacologic therapies exist for age-related macular degeneration (AMD), however none have satisfactory results. This underlines the need for novel drug delivery systems to improve pharmacological drug concentrations at specific locations, thereby boosting treatment effects. This study includes the current findings on sustained drug delivery systems focused at improving treatment results for patients with AMD.